A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Completed · Not applicable

Conditions studied: Coronary Artery Disease

In brief

The Provisional Heparin TherApy on Radial Artery Occlusion after transradial coronary angiography and patent Hemostasis (PHARAOH) study compares the strategy of standard a-priori heparin use in patients undergoing transradial coronary angiography to a strategy of provisional heparin administration only if patent hemostasis is not achievable.

Key facts

Study ID

NCT01489917

Run by

Olivier F. Bertrand

People needed

428

Starts

2009-05-01

Expected to finish

2011-12-01

Last updated by the study team

2012-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• all diagnostic cardiac cath patients

You may not qualify if…

• warfarin therapy
• previous ipsilateral TRA
• lack of consent
• abnormal (type D) Barbeau test
• scleroderma
• thrombocytopenia
• or other contraindications to heparin

Where it is running

• Commonwealth Medical College, — Scranton, Pennsylvania, United States
• IUCPQ — Québec, Quebec, Canada
• Sheth VS General Hospital, — Ahmedabad, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.